An Understanding

Cancer centers are increasingly testing patients' tumors for their genetic profiles to guide treatment, Bloomberg reports.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Amazing stuff! My oncologist

Amazing stuff! My oncologist had my brain tumor analyzed, and found the V600E BRAF mutation, which is typically associated with malignant melanoma. Turns out we were forced to turn to Zelboraf (Vemurafenib), which is designed for melanoma by targeting that mutation, when my cancer metastasized to my lungs! (Yes, that's right...primary brain tumor spreading to the lungs!) The drug has worked incredibly well! I'm back at work 10 weeks later, with NED!